• MYC (8q24) Gene Rearrangement by FISH
  • Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • Familial hyperlipoproteinemia
  • Urinary incontinence in men
  • Acylphosphatase 2 (ACYP2) Genotyping
  • Hemoglobin A2
  • Trypanosoma cruzi (T. cruzi) Antibody, IgM
  • Trichomonas vaginalis, Culture
  • Oxymorphone, Urine
  • Hepatitis B Virus (HBV) by Molecular Method, Quantitative (Viral Load)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

Interpretation
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.